ArticleHealth science reports2025
The Quality of Life in Kidney Transplant Recipients and Its Relation With the Use of Complementary and Alternative Medicine: A Cross-Sectional Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Kidney transplantation aims to enhance the quality of life (QOL) of individuals suffering from end-stage kidney disease. The evaluation of the QOL and effective factors in improving the QOL is of particular importance in kidney transplant recipients. Some studies have reported the high prevalence of the use of complementary and alternative medicine (CAM) in these patients. This study aims to measure QOL in kidney transplant patients and its relationship with the use of CAM in southeast Iran. Methods: A cross-sectional and descriptive correlational study was performed on 209 kidney transplant recipients referred to the office of medical specialists and Shafa Hospital in Kerman city from February to August 2021. Data were collected using demographic and clinical questionnaire, Kidney Transplant Questionnaire (KTQ-25) for the assessment of QOL and questionnaire on the use of CAMs. Results: Over half of the participants (52.2%) reported using at least one form of CAMs. The mean score of QOL was 3.22 (1.21). The highest mean score was related to physical symptom subscale 3.65 (1.58) and the lowest mean score was related to appearance subscale 2.22 (1.29). A significant correlation was found in the quality-of-life score and physical symptoms subscale between CAMs users and non-users ( Conclusions: Many kidney transplant recipients had a low QOL. The most important socio-demographic variables predicting and affecting the QOL in these patients included addiction, job, location, and marital status. Individuals who have received kidney transplants commonly use CAM. Users of CAM reported a higher QOL and fewer physical symptoms compared to non-users.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.